HOME >> BIOLOGY >> NEWS
Scientists identify new vaccine targets for cancer-causing strains of human papilloma virus

New vaccine approach may help treat and prevent pre-cancerous lesions and cervical cancer

San Diego, CA March 27, 2001 Epimmune Inc. (Nasdaq: EPMN) announced today that Company scientists, in collaboration with Loyola University, Chicago, IL, Leiden University Medical Center, The Netherlands, and University of Wales College of Medicine, Wales, UK, have identified new vaccine targets for cancer-causing strains of the human papilloma virus (HPV). The scientists reported in todays issue of the Journal of Clinical Cancer Research the discovery of four epitopes (protein fragments) from the virus that can induce a cellular immune response in human cells in vitro and may lead to an effective vaccine for treatment and prevention of cervical intraepithelial neoplasia (CIN), pre-cancerous lesions that develop into cervical cancer.

An estimated 20 million Americans are infected with HPV, a virus that is well known for causing genital warts but also accounts for over 95 percent of cervical cancer cases. CIN lesions, which precede most if not all cases of cervical cancer, occur in over 50,000 women in the United States each year. Currently, CIN is detected by PAP smear and treated by surgical removal of the pre-cancerous lesions, a costly procedure that may result in reproductive complications and requires continual post-surgery monitoring for recurrence. Epimmune is developing a vaccine that is designed to bolster the immune system against HPV, potentially providing a new way to treat and prevent both CIN and cervical cancer.

"Previous research has indicated that a cellular immune response led by cytotoxic T cells is capable of controlling tumor growth and destroying virus-infected cells in HPV-infected patients," said Alessandro Sette, Ph.D., Vice President and Chief Scientific Officer at Epimmune. "Our research shows that it may be possible to emulate this successful immune response with a vaccine that consists of epitopes from several
'"/>

Contact: Laura Hansen
lhansen@irpr.com
858-860-0266
Placeholder
26-Mar-2001


Page: 1 2 3

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... FREDERICK, Md. (PRWEB) , ... July 30, 2020 ... ... Business Innovation Research (SBIR) Phase II contract awarded by the Joint Science & ... goal of this project is to develop, optimize, and scale-up a highly efficient ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in Regenerative ... Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... effective way to complete one? Will the study comply with all FDA requirements? ...
(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... In most research ... to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic ... MA has been using the zebrafish model to investigate the causes of leukaemia ...
(Date:7/7/2020)... ... 06, 2020 , ... Bio-IT World has announced the winners ... the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance ... highlighting outstanding examples of how technology innovations and strategic initiatives can be powerful ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... today announced that the launch of a new clinical diagnostics immuno-oncology ... the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. (“Lumeda”), ... announced the company has entered a license agreement with Roswell Park Comprehensive Cancer ... exclusive rights to Roswell Park intellectual property surrounding a novel medical device and ...
Breaking Biology Technology:
Cached News: